{"id":697,"date":"2024-03-05T09:56:00","date_gmt":"2024-03-05T08:56:00","guid":{"rendered":"http:\/\/whitelab.fr\/?p=697"},"modified":"2024-03-06T09:56:54","modified_gmt":"2024-03-06T08:56:54","slug":"pilotitis-syndrome","status":"publish","type":"post","link":"https:\/\/whitelab.fr\/?p=697","title":{"rendered":"Pilotitis Syndrome!"},"content":{"rendered":"\n<p>\ud83d\ude05 Have you ever heard about the the &#8220;Pilotitis&#8221; affecting Pharma!?<br><br>Reading &#8220;The OmniAdvantage&#8221; by <a href=\"https:\/\/www.linkedin.com\/in\/ACoAAADMz0oBop6W7Hr64J1ho5SvHDzPIXjDHac\"><\/a><a href=\"https:\/\/www.linkedin.com\/in\/mehrnazcampbell\/\">Mehrnaz Campbell<\/a>, I came across a fascinating metaphor: &#8220;Pilotitis.&#8221; This &#8220;inflammatory condition&#8221; describes pharma&#8217;s tendency to launch short-term pilots that never truly take off.<br><br>\ud83d\uded1 What&#8217;s the problem? A disconnect exists between these isolated pilots and the long-term goals. This lack of mid-term strategy prevents pilots and long term goals from connecting, leaving us in a state of perpetual &#8220;pilot purgatory.&#8221;<br><br>\ud83d\udc68\u200d\u2695\ufe0f Why &#8220;Pilotitis&#8221;? Often, it stems from a risk-averse culture in commercial and marketing teams. Fear of failure and a lack of vision hinder our ability to embrace innovative approaches. Unfortunately, this creates an environment where we can&#8217;t fail, stifling creativity and progress.<br><br>\ud83d\udc8a So I was thinking about how Pharma can break free from this cycle!? Those are some tips :<br><br>1- Shift the mindset:\u00a0Reframe risk-taking as an opportunity for learning and growth, not just as a potential for failure.<br>2- Celebrate calculated risks and successes:\u00a0Showcase stories of successful pilots that led to positive outcomes, inspiring others to embrace calculated risks.<br>3- Invest in training:\u00a0Equip marketing and commercial teams with the skills and knowledge to assess risks effectively and develop mitigation strategies.<br>4- Integrate pilots into a broader strategic framework:\u00a0Clearly define how each pilot aligns with long-term goals and contributes to the overall marketing strategy.<br>5- Set clear success metrics:\u00a0Establish measurable objectives for each pilot, ensuring they contribute meaningfully to long-term goals.<br>6- Create a safe space for failure:\u00a0Encourage learning from mistakes and view them as opportunities for improvement, not as failures.<br>7- Encourage a growth mindset:\u00a0Foster a culture where learning and continuous improvement are valued and actively encouraged.<br><br>Are your Pharma suffering from Pilotitis? Share your stories!<br><br><a href=\"https:\/\/www.linkedin.com\/feed\/hashtag\/?keywords=pharmamarketing&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A7170674498864721920\">#pharmamarketing<\/a> <a href=\"https:\/\/www.linkedin.com\/feed\/hashtag\/?keywords=innovation&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A7170674498864721920\">#innovation<\/a> <a href=\"https:\/\/www.linkedin.com\/feed\/hashtag\/?keywords=riskmanagement&amp;highlightedUpdateUrns=urn%3Ali%3Aactivity%3A7170674498864721920\">#riskmanagement<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud83d\ude05 Have you ever heard about the the &#8220;Pilotitis&#8221; affecting Pharma!? Reading &#8220;The OmniAdvantage&#8221; by Mehrnaz Campbell, I came across a fascinating metaphor: &#8220;Pilotitis.&#8221; This &#8220;inflammatory condition&#8221; describes pharma&#8217;s tendency to launch short-term pilots that never truly take off. \ud83d\uded1 What&#8217;s the problem? A disconnect exists between these isolated pilots and the long-term goals. This &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/whitelab.fr\/?p=697\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pilotitis Syndrome!&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/whitelab.fr\/index.php?rest_route=\/wp\/v2\/posts\/697"}],"collection":[{"href":"https:\/\/whitelab.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/whitelab.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/whitelab.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/whitelab.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=697"}],"version-history":[{"count":1,"href":"https:\/\/whitelab.fr\/index.php?rest_route=\/wp\/v2\/posts\/697\/revisions"}],"predecessor-version":[{"id":698,"href":"https:\/\/whitelab.fr\/index.php?rest_route=\/wp\/v2\/posts\/697\/revisions\/698"}],"wp:attachment":[{"href":"https:\/\/whitelab.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/whitelab.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/whitelab.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}